Oxidants and antioxidants in atherosclerosis

被引：90

作者：

Mashima, R ^{[1
]}

Witting, PK ^{[1
]}

Stocker, R ^{[1
]}

机构：

[1] Heart Res Inst, Biochem Grp, Camperdown, NSW 2050, Australia

来源：

CURRENT OPINION IN LIPIDOLOGY | 2001年 / 12卷 / 04期

关键词：

D O I：

10.1097/00041433-200108000-00007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The oxidative theory suggests that LDL oxidation contributes to atherogenesis, implying that attenuation of this process by antioxidants should decrease atherosclerosis. However, a causative link between LDL oxidation and atherogenesis is not firmly established. It requires the identification of the oxidants that are responsible for the initiation of LDL oxidation, and an understanding of the modified moieties that are responsible for the proatherogenic activities of oxidized LDL. The present review summarizes recent data on potential biological oxidants for LDL in the vessel wall, and discusses the antiatherogenic role(s) of selected antioxidants. Curr Coin Lipidol 12:411-418. (C) 2001 Lippincott Williams & Wilkins.

引用

页码：411 / 418

页数：8

共 105 条

[11] A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit [J].

Bocan, TMA ;

Rosebury, WS ;

Mueller, SB ;

Kuchera, S ;

Welch, K ;

Daugherty, A ;

Cornicelli, JA .

ATHEROSCLEROSIS, 1998, 136 (02) :203-216

[12] PREVENTION OF TOCOPHEROL-MEDIATED PEROXIDATION IN UBIQUINOL-10-FREE HUMAN LOW-DENSITY-LIPOPROTEIN [J].

BOWRY, VW ;

MOHR, D ;

CLEARY, J ;

STOCKER, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5756-5763

[13] Increased atherosclerosis in myeloperoxidase-deficient mice [J].

Brennan, ML ;

Anderson, MM ;

Shih, DM ;

Qu, XD ;

Wang, XP ;

Mehta, AC ;

Lim, LL ;

Shi, WB ;

Hazen, SL ;

Jacob, JS ;

Crowley, JR ;

Heinecke, JW ;

Lusis, AJ .

JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04) :419-430

[14] Vitamin E:: function and metabolism [J].

Brigelius-Flohé, R ;

Traber, MG .

FASEB JOURNAL, 1999, 13 (10) :1145-1155

[15] PROBUCOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN HYPERCHOLESTEROLEMIA [J].

BUCKLEY, MMT ;

GOA, KL ;

PRICE, AH ;

BROGDEN, RN .

DRUGS, 1989, 37 (06) :761-800

[16]

Carr AC, 2000, CIRC RES, V87, P349, DOI 10.1161/01.RES.87.5.349

[17] Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload [J].

Chen, K ;

Suh, J ;

Carr, AC ;

Morrow, JD ;

Zeind, J ;

Frei, B .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (06) :E1406-E1412

[18] The oxidative modification hypothesis of atherogenesis: An overview [J].

Chisolm, GM ;

Steinberg, D .

FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1815-1826

[19] Effects of probucol on vascular remodeling after coronary angioplasty [J].

Côté, G ;

Tardif, JC ;

Lespérance, J ;

Lambert, J ;

Bourassa, M ;

Bonan, R ;

Gosselin, G ;

Joyal, M ;

Tanguay, JF ;

Nattel, S ;

Gallo, R ;

Crépeau, J .

CIRCULATION, 1999, 99 (01) :30-35

[20] Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice [J].

Cyrus, T ;

Witztum, JL ;

Rader, DJ ;

Tangirala, R ;

Fazio, S ;

Linton, MF ;

Funk, CD .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1597-1604

← 1 2 3 4 5 6 7 8 9 10 →